Palazestrant

Selleck Chemicals

Palazestrant

9

Research Use Only

...

Palazestrant(OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.

51202000